Skip to content

Investigation of biomarkers for diagnosis and treatment of pulmonary hypertension.

Investigation of biomarkers for diagnosis and treatment of pulmonary hypertension. - Biomarkers for pulmonary hypertension.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000032888
Enrollment
50
Registered
2018-07-01
Start date
2018-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary hypertension

Interventions

None listed

Sponsors

Juntendo University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient who is diagnosed as pulmonary hypertension including from group 1 to 5 in international classification.

Exclusion criteria

Exclusion criteria: Patient who has not undergone right heart catheterization and has not reached definite diagnosis of pulmonary hypertension.

Design outcomes

Primary

MeasureTime frame
level of serum periostin. Profile of microRNA and protein in exosome from blood sample.

Countries

Japan

Contacts

Public ContactTetsutaro Nagaoka

Juntendo University Division of respiratory medicine

jnagaoka@juntendo.ac.jp03-5802-1063

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026